World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
97
Citations
29437
World Ranking
1774
National Ranking
980

Medicine

D-Index
96
Citations
29124
World Ranking
9793
National Ranking
5032

Overview

Fatih M. Uckun is affiliated with the University of Southern California in the United States. Their research primarily spans the field of Medicine, with a particular focus on subfields such as Infectious Diseases, Oncology, Hematology, Neurology, and Immunology.

Their recent published papers include:

  • Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma, 2021, Cancers
  • Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug, 2021, Frontiers in Pharmacology
  • A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome, 2021, Cancers

Frequent coauthors of Fatih M. Uckun include:

  • Kazım Şahin
  • Cemal Orhan
  • Sanjive Qazi
  • Taha Koray Şahin
  • İbrahim H. Özercan

The research topics extensively covered by Uckun involve:

  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Acute Myeloid Leukemia Research
  • CAR-T Cell Therapy Research
  • Vitamin C and Antioxidants Research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 and Healthcare Impacts

Fatih M. Uckun frequently publishes in the following venues:

  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Investigation
  • Frontiers in Pharmacology
  • Frontiers in Oncology

Their work reflects a focus on immunology and hematology related to cancer, particularly leukemia, as well as extensive research on COVID-19, covering both therapeutic strategies and broader healthcare impacts.

Best Publications

  • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

    M Smith;D Arthur;B Camitta;A J Carroll

  • Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.

    James B. Nachman;Harland N. Sather;Martha G. Sensel;Michael E. Trigg

  • Reactive oxygen intermediates activate NF-kappa B in a tyrosine kinase- dependent mechanism and in combination with vanadate activate the p56lck and p59fyn tyrosine kinases in human lymphocytes

    Gary L. Schieven;Jean M. Kirihara;Dorothea E. Myers;Jeffrey A. Ledbetter

  • Dimeric drug polymeric nanoparticles with exceptionally high drug loading and quantitative loading efficiency

    Kaimin Cai;Xi He;Xi He;Ziyuan Song;Qian Yin

  • Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

    FM Uckun;WE Evans;CJ Forsyth;KG Waddick

  • Structure-based Design of Specific Inhibitors of Janus Kinase 3 as Apoptosis-inducing Antileukemic Agents

    Elise A. Sudbeck;Xing-Ping Liu;Rama Krishna Narla;Sandeep Mahajan

  • Regulation of human B-cell ontogeny.

    FM Uckun

  • Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies.

    Joyce M. Zarling;Patricia A. Moran;Omar Haffar;Joan Sias

  • Rational Design and Synthesis of a Novel Anti-leukemic Agent Targeting Bruton′s Tyrosine Kinase (BTK), LFM-A13 [α-Cyano-β-Hydroxy-β-Methyl-N-(2,5-Dibromophenyl)Propenamide]

    Sandeep Mahajan;Sutapa Ghosh;Elise A. Sudbeck;Yaguo Zheng

  • Early Response to Therapy and Outcome in Childhood Acute Lymphoblastic Leukemia A Review

    Paul S. Gaynon;Anish A. Desai;Bruce C. Bostrom;Raymond J. Hutchinson

  • Detailed Studies on Expression and Function of CD19 Surface Determinant by Using B43 Monoclonal Antibody and the Clinical Potential of Anti-CD19 Immunotoxins

    Fatih M. Uckun;Waclaw Jaszcz;Julian L. Ambrus;Anthony S. Fauci

  • Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia

    Fatih M. Uckun;Martha G. Sensel;Lei Sun;Peter G. Steinherz

  • Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.

    Gregory H. Reaman;Richard Sposto;Martha G. Sensel;Beverly J. Lange

  • Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia : A report from the children's cancer group

    Nyla A. Heerema;James B. Nachman;Harland N. Sather;Martha G. Sensel

  • BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells.

    Fatih M. Uckun;Kevin G. Waddick;Sandeep Mahajan;Xiao Jun

  • Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia

    Lei Sun;Nyla Heerema;Lisa Crotty;Xian Wu

  • Prognostic Impact of Trisomies of Chromosomes 10, 17, and 5 Among Children With Acute Lymphoblastic Leukemia and High Hyperdiploidy (> 50 Chromosomes)

    Nyla A. Heerema;Harland N. Sather;Martha G. Sensel;Tracy Zhang

  • Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.

    Fatih M. Uckun;Kazimiera Gajl-Peczalska;Dorothea E. Myers;Waclaw Jaszcz

  • Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex

    Alexei Vassilev;Zahide Ozer;Christopher Navara;Sandeep Mahajan

  • Clinical development of microbicides for the prevention of HIV infection.

    Osmond J D'Cruz;Fatih M Uckun

Frequent Co-Authors

Paul S. Gaynon
Paul S. Gaynon University of Southern California
Harland N. Sather
Harland N. Sather University of Southern California
John H. Kersey
John H. Kersey University of Minnesota
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Jianjun Cheng
Jianjun Cheng University of Illinois at Urbana-Champaign
Daniel A. Vallera
Daniel A. Vallera University of Minnesota
Norma K.C. Ramsay
Norma K.C. Ramsay University of Minnesota
Yanhong Dong
Yanhong Dong University of Minnesota
Kazim Sahin
Kazim Sahin Fırat University
Jeffrey A. Ledbetter
Jeffrey A. Ledbetter University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online pathways can open new doors for students in Biology and Biochemistry. Many graduates consider specialized healthcare careers, such as advanced nursing. For example, psych np programs offer a blend of mental health expertise and biology knowledge, making them a strong fit for those with a science background.

Nutrition science is another booming field. The fastest nutrition degree options let students fast-track their qualifications and enter the job market sooner, building on biochemistry foundations.

For those interested in management, online healthcare mba programs can make science graduates highly competitive for leadership roles in hospitals, clinics, or biomedical firms.

Career advancement often involves certification. Understanding the differences between ccs vs cpc certification can help you decide which credential is best suited for work in clinical coding or healthcare data.

With so many flexible online options, students and professionals in Biology and Biochemistry can tailor their education and advance in specialized fields across the healthcare sector.

Best Scientists Citing Fatih M. Uckun

Trending Scientists